FDA ANDA · ANDA071402

METOCLOPRAMIDE

Sponsor: ANI PHARMS

APPLICATION

ANDA071402

TYPE

ANDA

ORIGINAL APPROVAL

1993-06-25

LATEST ACTION

2015-07-28

ROUTE

ORAL

DOSAGE FORM

SOLUTION

MARKETING STATUS

Prescription

Products

METOCLOPRAMIDE HYDROCHLORIDEPrescription

METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/5ML · SOLUTION · ORAL

2015-07-28Labeling · Supplement 12 · standardAP

2014-12-16Labeling · Supplement 5AP

2012-07-31Labeling · Supplement 11 · standardAP

2011-02-28Labeling · Supplement 10AP

2010-03-31Labeling · Supplement 9AP

2009-09-16Labeling · Supplement 8 — Review ↗AP

2009-06-30Labeling · Supplement 7 — Review ↗AP

2008-10-28Labeling · Supplement 6AP

1993-06-25OriginalAP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.